REQUEST A DEMO
Total
USD $0.00
Search more companies

Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Remegen Co., Ltd. Profile Updated: March 15, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) is based in China, with the head office in Yantai. It operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on July 04, 2008. The total number of employees is currently 3,332 (2022). From the latest financial highlights, Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) reported a net sales revenue increase of 89.36% in 2025. Its total assets grew by 31.82% over the same period.

Headquarters
No. 58, Beijing Middle Road, Yantai Development Zone, Yantai Area, China (Shandong) Pilot Free Trade Zone, Shandong Province
Yantai; Shandong; Postal Code: 264006

Contact Details: Purchase the Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) report to view the information.

Website: http://www.remegen.cn

Basic Information
Total Employees:
Purchase the Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) report to view the information.
Registered Capital:
Purchase the Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) report to view the information.
Financial Auditors:
Purchase the Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) report to view the information.
Incorporation Date:
July 04, 2008
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
34.83%
Purchase this report to view the information.
18.81%
Purchase this report to view the information.
4.82%
Purchase this report to view the information.
3.4%
Purchase this report to view the information.
3.06%
Subsidiaries
RemeGen Australia Pty Ltd
100%
Remegen Biosciences, Inc.
100%
Rongchang Bio-Hong Kong Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
89.36%
Total Operating Revenue
126.78%
Operating Profit
N/A
Net Profit/Loss for the Period
N/A
Total Assets
31.82%
Total Equity
81.69%
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
-60636%
Quick Ratio
442.7%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?